Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,888,500 | 4,448,800 | 2,902,900 | 1,408,800 | 4,474,000 |
| Depreciation Amortization | 680,600 | 567,600 | 238,100 | 121,100 | 650,500 |
| Income taxes - deferred | 67,100 | 28,400 | 71,600 | 228,000 | 108,300 |
| Accounts receivable | 68,800 | -2,400 | -2,900 | -136,600 | -205,200 |
| Other Working Capital | 199,300 | -60,600 | 116,300 | -146,800 | 400,200 |
| Other Operating Activity | 174,300 | 136,600 | 97,500 | -15,000 | 759,900 |
| Operating Cash Flow | $7,078,600 | $5,118,400 | $3,423,500 | $1,459,500 | $6,187,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -514,500 | -404,100 | -314,000 | -127,100 | -770,600 |
| Net Acquisitions | -120,700 | 623,700 | -1,044,400 | -300,000 | -1,962,900 |
| Purchase Of Investment | -5,252,600 | -4,052,100 | -2,075,100 | -825,000 | -8,371,399 |
| Sale Of Investment | 6,486,300 | 4,343,600 | 3,565,500 | 1,489,200 | 9,173,700 |
| Purchase Sale Intangibles | -155,000 | -744,400 | 0 | 0 | -115,500 |
| Other Investing Activity | -128,000 | -749,000 | -4,000 | 1,700 | -115,101 |
| Investing Cash Flow | $470,500 | $-237,900 | $128,000 | $238,800 | $-2,046,300 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -3,200 |
| Common Stock Issued | N/A | -16,900 | -23,600 | -32,200 | N/A |
| Common Stock Repurchased | -5,868,300 | -3,775,200 | -3,057,300 | -655,800 | -4,352,600 |
| Other Financing Activity | 7,900 | 48,100 | 25,900 | 8,700 | -116,200 |
| Financing Cash Flow | $-5,860,400 | $-3,744,000 | $-3,055,000 | $-679,300 | $-4,472,000 |
| Exchange Rate Effect | 400 | -17,200 | 2,300 | -400 | -18,600 |
| Beginning Cash Position | 1,224,600 | 1,224,600 | 1,224,600 | 1,224,600 | 1,573,800 |
| End Cash Position | 2,913,700 | 2,343,900 | 1,723,400 | 2,243,200 | 1,224,600 |
| Net Cash Flow | $1,689,100 | $1,119,300 | $498,800 | $1,018,600 | $-349,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,078,600 | 5,118,400 | 3,423,500 | 1,459,500 | 6,187,700 |
| Capital Expenditure | -514,500 | -404,100 | -314,000 | -127,100 | -770,600 |
| Free Cash Flow | 6,564,100 | 4,714,300 | 3,109,500 | 1,332,400 | 5,417,100 |